T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin
about
Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML PatientsChronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants.Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants.Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.Rapid reconstitution of antibody responses following transplantation of purified allogeneic hematopoietic stem cellsAllogeneic T cells impair engraftment and hematopoiesis after stem cell transplantationImpact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignanciesEngineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networReduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maResponse to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation.Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblingsCo-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunityArrhythmias in the setting of hematopoietic cell transplants.Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell tCD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseHigh Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.Advances in the treatment of acute graft-versus-host disease.Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutation.Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning.Novel strategies for adoptive therapy following HLA disparate transplantsT cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
P2860
Q26799602-25E691AF-57A2-472E-B5A5-A790B7B1A922Q33388255-DF7C80C1-438E-4864-87A3-EB3DD8825AA7Q33633514-62722131-41A4-49B7-BA90-2EFBB21778C6Q33745865-05A84C63-6EED-4B2F-A66A-C91880EA1715Q33745878-5E8FD523-18A0-48BF-A7AE-3F345011EDEEQ33760933-8C6B07AD-B0A8-45A5-813B-732C287AB4A3Q33917645-213A25BC-393E-4EA2-A944-B0C85A8D4622Q34093150-51206A29-2B12-4F71-AEAD-4AE719926747Q34175284-CF29CD0D-35F6-4B39-BD4B-FC74B4423D3DQ34279672-750D0171-1FD9-4452-99DF-72A19AF90061Q34981585-92468C38-6FDB-4D0D-847B-2A8F79236F4FQ35094029-BC459ADB-4CF7-49F0-A841-078C3DD7BDEEQ35148420-12A84727-6AA7-4034-BAEA-D060045E01FCQ35167190-66F75784-2482-4C32-A8A4-6D02BB4276A0Q35243578-327E5CCD-4A5D-4FE5-A5C8-D20F699679CBQ35605318-0593BC4C-D9E6-4096-BD1C-A3DBB79E6940Q35623591-9EB8B013-8E61-4F3D-8897-ECD6FD949CA2Q35778492-3D3F2875-5C07-410D-AF69-1AA95F7B30C7Q35838113-FA936EFA-2154-4788-9D73-E2D2BA6706CEQ35889265-5D2F88E2-F32A-494C-9CE5-DEF905877889Q36021536-063A98D8-3600-4E8F-98E8-90FCE5ECFA81Q36040293-B2DA56F7-5A12-43C6-A131-4E88536544D7Q36212392-90DFD909-5453-43CB-B009-CEA111163D39Q36608689-A03C7E7D-77A0-4D51-9F6A-AB6898924E16Q36622322-47C3CD66-407A-468E-AD0E-2346071477A6Q36674480-32B7723C-E87C-49C0-841C-080952F4419AQ36863098-56D77C8C-8F51-4265-9234-D5C7C791DEB1Q37000485-8FEC3863-262E-4842-9FD3-603A6DD3219DQ37139105-C3844ACB-71A1-45A3-80B4-D08F611C22E7Q37143051-810C5ACE-55D0-46C4-B1FC-941C952310EFQ37191057-ACBF22EE-C66E-4439-9DF4-C524970CD62CQ37201899-F8EDF1D0-E72A-477F-A35F-4248C98CF5DBQ37291642-B8F847DC-6CB7-4DE2-8A73-4092DB9742EAQ37316816-0C2B1289-7422-4CA4-9513-E5998AE4A76CQ37395170-15441961-98C3-4CD2-A150-F721F01661BBQ37504394-51471964-E050-4004-984B-63908F12A63DQ37659142-016447E2-8070-4C1F-84A1-F9A9DB7F9956Q38514497-D56AB739-CEB9-45A7-8F49-F90C3E6EF6E7Q39028818-6879C493-4F09-4205-A020-844A957091D7Q40121414-02AECD08-0C8A-45E0-A05F-08CE918F5E96
P2860
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
T cell depleted stem-cell tran ...... use of antithymocyte globulin
@ast
T cell depleted stem-cell tran ...... use of antithymocyte globulin
@en
type
label
T cell depleted stem-cell tran ...... use of antithymocyte globulin
@ast
T cell depleted stem-cell tran ...... use of antithymocyte globulin
@en
prefLabel
T cell depleted stem-cell tran ...... use of antithymocyte globulin
@ast
T cell depleted stem-cell tran ...... use of antithymocyte globulin
@en
P2093
P2860
P1433
P1476
T cell depleted stem-cell tran ...... use of antithymocyte globulin
@en
P2093
Ann A Jakubowski
Christine Cisek
Esperanza B Papadopoulos
Hugo Castro-Malaspina
James W Young
Katherine C Hsu
Marcel R M van den Brink
Michelle Chiu
Miguel-Angel Perales
Nancy Collins
P2860
P304
P356
10.1182/BLOOD-2007-06-093880
P407
P577
2007-08-23T00:00:00Z